A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis
Clinical trial NCT01085097 · COMPLETED
Trial details
- NCT number
- NCT01085097
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-10-24
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.